Europe Cancer Immunotherapy Market Analysis 2017-2023 - Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technologies - ResearchAndMarkets.com Print
Business Wire
Thursday, 08 March 2018 04:06
ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs
March 8, 2018 14:25 UTC

Europe Cancer Immunotherapy Market Analysis 2017-2023 - Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technologies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)-- The "Europe Cancer Immunotherapy Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

The Europe Cancer Immunotherapy Market would witness market growth of 14.1% CAGR during the forecast period 2017-2023

The key factors driving the growth of cancer immunotherapy market are rising incidence and prevalence of cancer, technologically advanced treatment therapies, Growing R&D activities to treat cancer, and specificity & effectiveness of cancer immunotherapy for the treatment of wide range of cancers such as lung cancer, breast cancer, skin cancer, and others.

Also, growing healthcare expenditure and better healthcare insurance coverage would further add to the market growth during the analysis period. Nevertheless, lack of professional healthcare experts and limited awareness about possible solutions among the population are the factors that limit the growth.

Scope of the Report

  • Based on Technology, the market report segments the market into Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technology.
  • End user is segmented into Polymeric Coatings and Organic Coatings.
  • The Application covered under the report includes Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Other Cancer.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Europe Cancer Immunotherapy Market

Chapter 4. Europe Cancer Immunotherapy Market by End User

Chapter 5. Europe Cancer Immunotherapy Market by Application

Chapter 6. Europe Cancer Immunotherapy Market by Country

Chapter 7. Company Profiles

  • Novartis AG
  • Astrazeneca Plc.
  • Amgen Inc.
  • Immunomedics, Inc.
  • Bayer AG
  • Pfizer Inc.
  • Bristol-Myers Squibb
  • Merck Sharp & Dohme Corp.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/cxhfjq/europe_cancer?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs


Source: Research and Markets




BiomedReports is not paid or compensated by newswires to disseminate or report news and
developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and

Error. Page cannot be displayed. Please contact your service provider for more details. (12)

investor relation services from various entities and
firms. Full disclosures should be read in the 'About Us Section'.


Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
  BMR:1